CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-21 | PATEL DINESH V PH D President and CEO | Sale | −15,000 | $32.14 | $482K | 477,158 |
| 2021-09-21 | PATEL DINESH V PH D President and CEO | Option exercise | +40,000 | $4.21 | $168K | 492,158 |
| 2021-09-21 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −40,000 | 125,742 | ||
| 2021-08-17 | Liu David Y Chief Scientific Officer | Option exercise | +10,000 | $0.87 | $9K | 73,033 |
| 2021-08-17 | Liu David Y Chief Scientific Officer | Sale | −14,779 | $47.56 | $703K | 58,254 |
| 2021-08-17 | Liu David Y Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −10,000 | 13,767 | ||
| 2021-05-27 | Williams Lewis T Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-05-27 | Waddill William D. Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-05-27 | SELICK HAROLD E Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-05-27 | O'Dowd Sarah A Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-05-27 | Noonberg Sarah B. Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-05-27 | Giraudo Bryan Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2021-02-26 | Saks Samuel R Chief Medical Officer | Grant or award | +12,000 | 14,000 | ||
| 2021-02-26 | Saks Samuel R Chief Medical Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2021-02-26 | PATEL DINESH V PH D President and CEO | Grant or award | +25,000 | 451,144 | ||
| 2021-02-26 | PATEL DINESH V PH D President and CEO | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2021-02-26 | Liu David Y Chief Scientific Officer | Grant or award | +10,000 | 62,427 | ||
| 2021-02-26 | Liu David Y Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2021-02-26 | Kalkofen Donald A. Chief Financial Officer | Grant or award | +7,500 | 10,386 | ||
| 2021-02-26 | Kalkofen Donald A. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 |
Page 18 of 29 · 580 trades